Financials

News Ideas Discussions Technicals Forecast Seasonals Options

BCRX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of BioCryst Pharmaceuticals, Inc.

Total assets of BCRX for Q1 25 is 480.05 M USD, 2.12% less than the previous Q4 24. And total liabilities decreased by 3.56% in Q1 25 to 931.97 M USD.

Q2 '17

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD